Allergic bronchopulmonary aspergillosis in cystic fibrosis

Curr Opin Pulm Med. 2000 Nov;6(6):540-4. doi: 10.1097/00063198-200011000-00014.


The current standards of care for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis are presented. Recent studies have increased understanding of the inflammatory process that occurs in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. This has resulted in more precise diagnostic criteria that facilitate more timely diagnosis and treatment of ABPA in these patients. In addition to traditional treatment with systemic corticosteroids, promising results have been documented with antifungal therapy.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Aspergillosis, Allergic Bronchopulmonary / complications
  • Aspergillosis, Allergic Bronchopulmonary / diagnosis*
  • Aspergillosis, Allergic Bronchopulmonary / immunology
  • Aspergillosis, Allergic Bronchopulmonary / therapy*
  • Cystic Fibrosis / complications*
  • Humans
  • Itraconazole / therapeutic use


  • Antifungal Agents
  • Itraconazole